Join our community of smart investors

Covid testing demand boosts Porvair

High demand for diagnostic products offset weakness from the aerospace and industrial sectors
July 5, 2021
  • Laboratory sales surged by a third year on year in the six months to 31 May
  • The group’s adjusted operating profit increased by 4 per cent at constant currencies to £9.1m

Filtration and environmental technology specialist Porvair (PRV) saw its revenue dip by just 2 per cent at constant currencies in the six months to 31 May, to £69.7m. While the group’s 'aerospace and industrial' and 'metal melt quality' businesses were hindered by the pandemic, laboratory sales jumped by a third on the back of higher demand for Covid-19-related diagnostic products.

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in